Tenderwize
Back to tender search

Open House Discount Agreements for Cabotegravir (Depot Injection Suspension)

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 03, 2028 · 596 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Cabotegravir in der Darreichungsform Depot-Injektionssuspension, ATC J05AJ04

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

30 / 100

Risk factors

No estimated value or guaranteed purchase volume; participation may not yield significant business.

Open-house model is not subject to procurement law; legal recourse lies with social courts, not procurement chambers.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2028
  • Conclusion of non-exclusive discount agreements for Cabotegravir (ATC J05AJ04) in depot injection suspension form.
  • Agreements are identical for all participants and not individually negotiable.
Show full summary

AOK Bayern is offering non-exclusive discount agreements under an open-house model for the pharmaceutical product Cabotegravir (ATC J05AJ04, depot injection suspension) to all interested pharmaceutical companies that meet eligibility criteria. The contract runs from June 2026 to May 2028, with possible termination under certain conditions. This is not a standard procurement procedure; participation is open, but no estimated value is provided.

Risks

No estimated value or guaranteed purchase volume; participation may not yield significant business.

Open-house model is not subject to procurement law; legal recourse lies with social courts, not procurement chambers.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible.

Administrative

  • Submission of a signed self-declaration of reliability, signed contract, and filled annex on medicinal products.
  • Documents must be submitted either in paper form (two original copies) or electronically with a qualified electronic signature.

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open House Discount Agreements for Cabotegravir (Depot Injection Suspension)

Single lot covering all agreements for Cabotegravir. The open-house model allows any eligible pharmaceutical company to conclude identical, non-negotiable discount agreements. The contract period is from 01.06.2026 to 31.05.2028, with rolling monthly cutoff for document submission.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

May 2026 - May 2028

Category

Pharmaceutical products

Deadline

Deadline Apr 03, 2028

Procurement Details

Publication date
14 Apr 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
257297-2026

Documents (2)

Similar tenders